blue-line-4
ryan-pawell.2e16d0ba.fill-340x340.2e16d0ba.fill-340x340
Ryan Pawell (Founder, Managing Director & Chief Executive Officer) is a Y Combinator alumnus, published author and subject matter expert in the areas of fluid dynamics, advanced manufacturing, and biomicrofluidics. He has produced 7 peer-reviewed publications, received multiple granted patents across 3 patent families and raised seed-stage funding from various sources in the United States (SOSV/IndieBio, Y Combinator, Social Capital and Founders Fund's FF Science) and Australia (Jobs for NSW, AusIndustry, Main Sequence Ventures, MTP Connect BioMedTech Horizons, Australian Research Council and NSW Health Medical Device Fund). Ryan has also been invited to present his work by the Australian National Fabrication Facility, White House Cancer Moonshot Taskforce, Air Force Office of Scientific Research, Air Force Research Laboratory, National Institutes of Health, National Cancer Institute, Mayo Clinic, QB3, Stanford and the Economist among others. 

linkedin-blue   twitter-blue   email
Katherine_Head_shot.8e52d9db.fill-340x340
Katherine Lau (Bioengineer and Laboratory Supervisor) is a graduate from the University of California, Berkeley (MEng) and Rutgers University (B.S.) with over 5 years of research experience. Katherine has previously worked on several BioMEMS projects including the fabrication of microcatheters for drug delivery in the brain and in vitro studies of neuron growth in microchannels after injury.

linkedin-blue
Adrian_Lievano.2e16d0ba.fill-340x340
Adrian Lievano (Bioengineer) is a graduate from the University of Pennsylvania (B.S.E & M.S.E) with over 3 years of entrepreneurial experience. Adrian previously served as a research engineer at UPENN's GRASP laboratory, where he worked on autonomous robotic systems, haptic sensors, and haptic actuation systems.

linkedin-blue   twitter-blue

justin.2e16d0ba.fill-340x340
Justin Jarrell, PhD (Senior Scientist) is a translational immunologist with 9 years of experience directing projects in human disease, biomarker and drug target discovery, and high-throughput platform development. He recently completed his PhD in Immunology at Stanford University where he discovered and implicated anti-cytokine autoantibodies in the pathogenesis of IgG4-related disease. Prior to this, Justin worked as a research associate at Stanford developing novel antigen microarrays to investigate B and T cell responses in lupus and influenza. He is an author of 12 peer-reviewed publications, recipient of the Stanford Graduate Fellowship, and is eager to apply his technical expertise, clinical knowledge, and immunology foundation to advance Indee’s gene delivery system for CAR T cell production and manufacturing.

linkedin-blue   twitter-blue
Leah Wilson (Bioengineer)
Leah Wilson (Bioengineer) is a graduate from University of California, Davis and has 4 years of Research Experience. Leah was previously in the Cannabis Industry working as a Lab Technician, where she tested cannabis products for bacterial and fungal pathogens via PCR, and tested products chemically by working with analytical instrumentation, and analysing data by interpreting chromatographs.

linkedin-blue   
blue-line-4

Advisors

heidi-hagen.2e16d0ba.fill-340x340

Heidi Hagen (Advisor)
 is co-founder and Chief Strategy Officer at Vineti with more than 15 years experience in commercial cell therapy. Prior to this, she successfully delivered the first operation that manufactures and distributes live autologous cellular products within an 18 hour time window to oncology patients in both the United States and Europe.
blue-line-4
indee-labs-logos-2
blue-line-4